用可信的活体证据合成与指南制定为德国的大流行病管理提供信息:来自COVID-19证据生态系统的经验教训
本文介绍德国COVID-19证据生态系统(CEOsys)网络,该网络联合18所大学医院及其他机构,开展研究优先排序、活体系统评价、支持活体指南、知识转化与识别研究空白等活动。CEOsys快速产出31项高质量证据合成并支持3部活体指南,同时指出启动较晚、研究问题优先排序延迟、证据持续演变及技术基础设施建设等挑战,为类似网络提供经验教训。
要点
- CEOsys联合18所大学医院及其他机构,快速产出31项高质量证据合成并支持3部COVID-19相关活体指南。
- 主要挑战包括网络启动较晚、研究问题优先排序延迟、证据持续演变及技术基础设施建设。
- 方法学-临床结对、与国家指南组合作及国际协作是提升效率的关键。
核心结论
- CEOsys为国家层面的证据生态系统提供了概念验证。
- 类似网络应尽早纳入方法学与临床关键利益相关者、争取(国际)国家合作并系统评估其价值,作者特别呼吁建立可持续网络。
研究设计与样本
- CEOsys为德国网络,联合18所大学医院及其他机构。
- 关键活动包括研究优先排序、开展活体系统评价、支持基于证据的(活体)指南、知识转化、识别研究空白及推导推荐,并由技术基础设施和能力建设支持。
主要发现
- CEOsys快速产出31项高质量证据合成。
- CEOsys支持3部COVID-19相关主题的活体指南,同时开发方法学流程。
临床怎么用
- 原文未据此给出推荐。
局限性
- 挑战包括CEOsys相对于大流行暴发启动较晚。
- 研究问题的优先排序延迟。
- COVID-19相关证据持续演变。
- 建立技术基础设施存在挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We present the 'COVID-19 evidence ecosystem' (CEOsys) as a German network to inform pandemic management and to support clinical and public health decision-making. We discuss challenges faced when organizing the ecosystem and derive lessons learned for similar networks acting during pandemics or health-related crises. STUDY DESIGN AND SETTING: Bringing together 18 university hospitals and additional institutions, CEOsys key activities included research prioritization, conducting living systematic reviews (LSRs), supporting evidence-based (living) guidelines, knowledge translation (KT), detecting research gaps, and deriving recommendations, backed by technical infrastructure and capacity building. RESULTS: CEOsys rapidly produced 31 high-quality evidence syntheses and supported three living guidelines on COVID-19-related topics, while also developing methodological procedures. Challenges included CEOsys' late initiation in relation to the pandemic outbreak, the delayed prioritization of research questions, the continuously evolving COVID-19-related evidence, and establishing a technical infrastructure. Methodological-clinical tandems, the cooperation with national guideline groups and international collaborations were key for efficiency. CONCLUSION: CEOsys provided a proof-of-concept for a functioning evidence ecosystem at the national level. Lessons learned include that similar networks should, among others, involve methodological and clinical key stakeholders early on, aim for (inter)national collaborations, and systematically evaluate their value. We particularly call for a sustainable network.
引用
- Kunzler AM, Iannizzi C, Burns J, et al. Informing pandemic management in Germany with trustworthy living evidence syntheses and guideline development: lessons learned from the COVID-19 evidence ecosystem. J Clin Epidemiol. 2024. PMID: 39002765. doi:10.1016/j.jclinepi.2024.111456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。